You are here

nDatalyze Corp.

nDatalyze Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
NDAT
CSE Index: 
Currency: 

nDatalyze Corp. generates technology-based, health-related solutions. The YMI division has developed a machine-learning based, online consumer mental health application called YMI. YMI is based on the Corporation's proprietary Reference Database consisting of >1200 biometric records complete with electroencephalogram ("EEG") "same-time-of-day" data. YMI has only recently been released and has begun a Clinical Study process to validate the approach and accuracy, accordingly the Corporation cannot accurately predict if or when this application will become a cash flow generator. Investors are encouraged to contact the Corporation by email at jimd@ndatalyze.com or by telephone at (403) 689-3901.

You are here

nDatalyze Corp. (NDAT)

SEDAR Information

Company Info

Address
1150, 707 - 7 Avenue SW
Calgary, AB T2P 3H6
Canada
Phone
403-689-3901
Email
jimd@ndatalyze.com
Website
https://www.ndatalyze.com
Listing date
Thursday, October 24, 2019
Transfer Agent
Odyssey Trust Company
Auditor
Kenway Mack Slusarchuk Stewart LLP

Capitalization

Issued & Outstanding: 
41027425
Reserved for Issuance: 
4847500

Company Officers

James M. Durward, Chief Executive Officer, Chief Technical Officer and Corporate Secretary
Dwayne Vinck, Chief Financial Officer
Dr. Keith Courtney, President and Chief Psychiatric Officer

News Releases

Bulletins

20/10/2021

2021-1022 – Name and Symbol Change - MedXtractor Corp. (MXT)

le 20 octobre/October 2021

MedXtractor Corp. has announced a name and symbol change to nDatalyze Corp. (NDAT)

Shares will begin trading under the new name, symbol and with a new CUSIP number on October 22, 2021.

Disclosure documents are available at www.thecse.com